Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Ivor, R.J.Mc
Davies, R.A.
Wieck, A.
Marks, M.N.
Brown, N.
Campbell, I.C.
Checkley, S.A.
and
Kumar, R.
1996.
The growth hormone response to apomorphine at 4 days postpartum in women with a history of major depression.
Journal of Affective Disorders,
Vol. 40,
Issue. 3,
p.
131.
Barili, Paolo
De Carolis, Gionni
Zaccheo, Damiano
and
Amenta, Francesco
1998.
Sensitivity to ageing of the limbic dopaminergic system: a review.
Mechanisms of Ageing and Development,
Vol. 106,
Issue. 1-2,
p.
57.
J. Henderson, Max
and
Mellers, John D.C.
2000.
Psychosis in Parkinson’s disease: ‘between a rock and a hard place’.
International Review of Psychiatry,
Vol. 12,
Issue. 4,
p.
319.
Aarsland, Dag
Litvan, Irene
and
Larsen, Jan P.
2001.
Neuropsychiatric Symptoms of Patients With Progressive Supranuclear Palsy and Parkinson's Disease.
The Journal of Neuropsychiatry and Clinical Neurosciences,
Vol. 13,
Issue. 1,
p.
42.
Ng Ying Kin, N.M.K.
Lal, Samarthji
and
Thavundayil, Joseph X.
2001.
Stability of apomorphine hydrochloride in aqueous sodium bisulphite solutions.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 25,
Issue. 7,
p.
1461.
Aymard, Guy
Berlin, Ivan
De Brettes, Benoît
and
Diquet, Bertrand
2003.
Pharmacokinetic–pharmacodynamic study of apomorphine's effect on growth hormone secretion in healthy subjects.
Fundamental & Clinical Pharmacology,
Vol. 17,
Issue. 4,
p.
473.
Takakusaki, K.
Saitoh, K.
Harada, H.
and
Kashiwayanagi, M.
2004.
Role of basal ganglia–brainstem pathways in the control of motor behaviors.
Neuroscience Research,
Vol. 50,
Issue. 2,
p.
137.
Marsh, L.
Williams, J. R.
Rocco, M.
Grill, S.
Munro, C.
and
Dawson, T. M.
2004.
Psychiatric comorbidities in patients with Parkinson disease and psychosis.
Neurology,
Vol. 63,
Issue. 2,
p.
293.
Schrag, Anette
Barone, Paolo
Brown, Richard G.
Leentjens, Albert F.G.
McDonald, William M.
Starkstein, Sergio
Weintraub, Daniel
Poewe, Werner
Rascol, Olivier
Sampaio, Cristina
Stebbins, Glenn T.
and
Goetz, Christopher G.
2007.
Depression rating scales in Parkinson's disease: Critique and recommendations.
Movement Disorders,
Vol. 22,
Issue. 8,
p.
1077.
Di Giuda, Daniela
Camardese, Giovanni
Bentivoglio, Anna Rita
Cocciolillo, Fabrizio
Guidubaldi, Arianna
Pucci, Lorella
Bruno, Isabella
Janiri, Luigi
Giordano, Alessandro
and
Fasano, Alfonso
2012.
Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study.
European Journal of Nuclear Medicine and Molecular Imaging,
Vol. 39,
Issue. 12,
p.
1937.
Ziomber, Agata
Thor, Piotr
Krygowska-Wajs, Anna
Załęcki, Tomasz
Moskała, Marek
Romańska, Irena
Michaluk, Jerzy
and
Antkiewicz-Michaluk, Lucyna
2012.
Chronic impairment of the vagus nerve function leads to inhibition of dopamine but not serotonin neurons in rat brain structures.
Pharmacological Reports,
Vol. 64,
Issue. 6,
p.
1359.
Surowka, Artur Dawid
Krygowska-Wajs, Anna
Ziomber, Agata
Thor, Piotr
Chrobak, Adrian Andrzej
and
Szczerbowska-Boruchowska, Magdalena
2015.
Peripheral Vagus Nerve Stimulation Significantly Affects Lipid Composition and Protein Secondary Structure Within Dopamine-Related Brain Regions in Rats.
NeuroMolecular Medicine,
Vol. 17,
Issue. 2,
p.
178.
Toh, Wei Lin
Yolland, Caitlin
Gurvich, Caroline
Barnes, James
and
Rossell, Susan L.
2023.
Non-visual hallucinations in Parkinson’s disease: a systematic review.
Journal of Neurology,
Vol. 270,
Issue. 6,
p.
2857.
eLetters
No eLetters have been published for this article.